我院1997年6月至1999年4月将收治的168例急性脑梗死(ACI)患者,分别采用血塞通和川芎嗪加甘露醇进行治疗,现将疗效对比观察结果报道如下。1 临床资料1．1 一般资料168例ACI患者,年龄≥49岁,男96例,女72例,均为首次发病,于发病72小时内入院,无糖尿病及心、肺、肝、肾病史;诊断依据中华医学会第四次全国脑血管病学术会议修订的诊断标准,均处于颈内动脉系统脑梗死的急性期,有不同程度的肢瘫症状,CT扫描可见脑梗死灶。男女患者分别按入院先后顺序随机分成A组和B组。两组患者的年龄、性别、病情程度、发病和开始给药时间、入院的平均动脉压及血脂、血糖水平等参数,经统计学处理均无显著性差异,两组患者受治疗和预 Our hospital from June 1997 to April 1999 will be treated 168 cases of acute cerebral infarction (ACI) patients were treated with Xuesaitong and ligustrazine plus mannitol, the efficacy of the comparison results are reported below. 1 Clinical data 1.1 General information 168 cases of ACI patients, aged 49 years or older, male 96 and female 72, were the first incidence, admission within 72 hours of onset, no history of diabetes and heart, lung, liver and kidney disease; Diagnosis According to the Fourth National Cerebrovascular Disease Conference of Chinese Medical Association revised diagnostic criteria, are in the acute stage of cerebral infarction of the carotid artery system, with varying degrees of limb paralysis, CT scan showed cerebral infarction. Male and female patients were randomly divided into group A and group B according to the sequence of admission. Two groups of patients age, gender, disease severity, onset and start time, admission average arterial pressure and blood lipids, blood glucose and other parameters, no statistically significant differences were found between the two groups of patients treated and pre-